Clinical Trials Browser

Phase 2/3 × Carcinoma, Hepatocellular × Thalidomide × Clear all

NCT07309419 2025-12-30

Cocktail-001

Phase 2/3 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular